株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

G-CSF (顆粒球コロニー刺激因子)バイオシミラーの世界市場 - 市場規模調査および地域別将来予測

Global G-CSF Biosimilars Market Size study, by Type, By Application and Regional Forecasts 2018-2025

発行 Bizwit Research & Consulting LLP 商品コード 784418
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.52円で換算しております。
Back to Top
G-CSF (顆粒球コロニー刺激因子)バイオシミラーの世界市場 - 市場規模調査および地域別将来予測 Global G-CSF Biosimilars Market Size study, by Type, By Application and Regional Forecasts 2018-2025
出版日: 2019年01月25日 ページ情報: 英文
概要

当レポートでは、G-CSF (顆粒球コロニー刺激因子)バイオシミラーの世界市場を取り上げ、市場成長促進要因や課題、市場動向、また市場競争状況に関する広範な調査を通じて市場の現状分析ならびに将来予測を行っています。さらに市場をタイプ別、適応症別、および地域別に分類し、それぞれ詳細な分析と予測とを提供しています。

第1章 エグゼクティブ・サマリー

  • 市場概観
  • 主要動向
  • 世界市場および分野別市場見積および将来予測
  • 見積手法
  • 調査上の想定条件

第2章 G-CSFバイオシミラー市場の定義と範囲

  • 本調査の目的
  • 市場の定義および範囲
  • 調査対象年
  • 通貨交換レート

第3章 G-CSFバイオシミラー市場ダイナミクス

  • シーソー分析
    • 市場成長促進要因
    • 市場の課題
    • 市場機会

第4章 G-CSFバイオシミラー市場の産業分析

  • Porterのファイブフォースモデル
  • PEST分析
  • バリューチェーン分析
  • 主要購買基準
  • 法規制の枠組み
  • コスト構成分析
  • 投資 vs 採用度シナリオ
  • アナリストの提言と結論

第5章 G-CSFバイオシミラー市場のタイプ別分析

  • 市場概観
  • 市場実績 - 将来性モデル
  • 主要企業
  • G-CSFバイオシミラー市場のタイプ別分析
    • ヒト成長ホルモン
    • エリスロポエチン
    • モノクローナル抗体
    • インスリン
    • インターフェロン
    • 顆粒球コロニー刺激因子

第6章 G-CSFバイオシミラー市場の適応症別分析

  • 市場概観
  • 市場実績 - 将来性モデル
  • 主要企業
  • G-CSFバイオシミラー市場の適応症別分析
    • 血液疾患
    • 腫瘍性疾患
    • 慢性病および自己免疫疾患
    • 成長ホルモン欠乏症

第7章 G-CSFバイオシミラー市場の地域別分析

  • G-CSFバイオシミラー市場の地域別市場概観
  • 北米のG-CSFバイオシミラー市場概観
    • 米国
    • カナダ
  • 欧州のG-CSFバイオシミラー市場概観
    • 英国
    • ドイツ
    • フランス
    • その他の欧州諸国
  • アジアのG-CSFバイオシミラー市場概観
    • 中国
    • インド
    • 日本
    • その他のアジア太平洋諸国
  • ラテンアメリカのG-CSFバイオシミラー市場概観
    • ブラジル
    • メキシコ
  • その他の地域
    • 南米
    • 中東およびアフリカ

第8章 市場競争情報

  • 企業別市場シェア
  • 最重要市場戦略
  • 企業プロファイル
    • Pfizer
    • Novartis
    • Roche
    • Merck & Co.
    • Sanofi
    • Johnson & Johnson
    • Gilead Science
    • GlaxoSmithKline
    • AbbVie
    • Amgen
    • AstraZeneca
    • Bayer

第9章 調査プロセス

図表

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF G-CSF BIOSIMILARS MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF G-CSF BIOSIMILARS MARKET
  • TABLE 3. G-CSF BIOSIMILARS MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. G-CSF BIOSIMILARS MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
  • TABLE 7. G-CSF BIOSIMILARS MARKET ESTIMATES & FORECASTS BY APPLICATION 2015-2025 (USD BILLION)
  • TABLE 8. G-CSF BIOSIMILARS MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)
  • TABLE 9. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 10. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 11. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 12. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 13. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 14. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 15. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 16. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 17. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 18. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 19. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 20. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 21. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 22. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 23. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 24. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 25. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 26. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 27. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 28. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 29. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 30. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 31. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 32. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 33. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 34. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 35. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 36. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 37. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 38. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 39. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 40. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 41. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 42. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 43. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 44. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 45. U.S. G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 46. U.S. G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 47. U.S. G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 48. U.S. G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 49. U.S. G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 50. CANADA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 51. CANADA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 52. CANADA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 53. CANADA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 54. CANADA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 55. UK G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 56. UK G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 57. UK G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 58. UK G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 59. UK G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 60. GERMANY G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 61. GERMANY G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 62. GERMANY G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 63. GERMANY G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 64. GERMANY G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 65. ROE G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 66. ROE G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 67. ROE G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 68. ROE G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 69. ROE G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 70. CHINA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 71. CHINA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 72. CHINA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 73. CHINA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 74. CHINA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 75. INDIA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 76. INDIA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 77. INDIA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 78. INDIA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 79. INDIA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 80. JAPAN G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 81. JAPAN G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 82. JAPAN G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 83. JAPAN G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 84. JAPAN G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 85. ROAPAC G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 86. ROAPAC G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 87. ROAPAC G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 88. ROAPAC G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 89. ROAPAC G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 90. BRAZIL G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 91. BRAZIL G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 92. BRAZIL G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 93. BRAZIL G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 94. BRAZIL G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 95. MEXICO G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 96. MEXICO G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 97. MEXICO G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 98. MEXICO G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 99. MEXICO G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 100. ROLA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 101. ROLA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 102. ROLA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 103. ROLA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 104. ROLA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 105. ROW G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 106. ROW G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 107. ROW G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 108. ROW G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 109. ROW G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

List of Figures

  • FIG 1. G-CSF BIOSIMILARS MARKET, RESEARCH METHODOLOGY
  • FIG 2. G-CSF BIOSIMILARS MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. G-CSF BIOSIMILARS MARKET, KEY TRENDS 2016
  • FIG 5. G-CSF BIOSIMILARS MARKET, GROWTH PROSPECTS 2017-2025
  • FIG 6. G-CSF BIOSIMILARS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. G-CSF BIOSIMILARS MARKET, PEST ANALYSIS
  • FIG 8. G-CSF BIOSIMILARS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 10. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 11. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 12. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 13. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 14. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 15. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 16. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 17. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 18. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 19. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 20. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 21. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 22. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 23. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 24. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 25. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 26. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 27. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 28. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 29. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 30. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 31. G-CSF BIOSIMILARS MARKET, REGIONAL SNAPSHOT 2015 & 2025
  • FIG 32. NORTH AMERICA G-CSF BIOSIMILARS MARKETMARKET 2015 & 2025 (USD BILLON)
  • FIG 33. EUROPE G-CSF BIOSIMILARS MARKETMARKET 2015 & 2025 (USD BILLON)
  • FIG 34. ASIA PACIFIC G-CSF BIOSIMILARS MARKETMARKET 2015 & 2025 (USD BILLON)
  • FIG 35. LATIN AMERICA G-CSF BIOSIMILARS MARKETMARKET 2015 & 2025 (USD BILLON)
  • FIG 36. G-CSF BIOSIMILARS MARKET, COMPANY MARKET SHARE ANALYSIS (2016)
目次

Global G-CSF Biosimilars Market to reach USD XX billion by 2025.

Global G-CSF Biosimilars Market valued approximately USD XX billion in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The G-CSF Biosimilars Market is continuously growing across the world over the coming years. Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000. GCSF stimulates granulocyte production in BM suppressed by chemotherapy and radiotherapy and reduces infections in cancer patients. It can induce terminal maturation of myeloid leukemia cells, resulting in complete hematologic and cytologic remission, and can suppress self-renewal. It is useful in patients with AIDS or leukemic relapse after allogeneic BM transplantation. Increasing aging population, growing incidence of chronic diseases and rising healthcare expenditure are the substantial driving factors of the market across the globe. In addition, growing acceptance due to their cost-effectiveness is also boosting the market growth over the upcoming years. Furthermore, patent expiry of biologic products is the major factor which creating numerous opportunity in the market over the coming years. However, complications associated with manufacturing of G-CSF biosimilars are the factors which limiting the market growth of G-CSF Biosimilars over the coming years. The regional analysis of Global G-CSF Biosimilars Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.

The major market player included in this report are:

  • Pfizer
  • Novartis
  • Roche
  • Merck & Co.
  • Sanofi
  • Johnson & Johnson
  • Gilead Science
  • GlaxoSmithKline
  • AbbVie
  • Amgen
  • AstraZeneca
  • Bayer

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Human Growth Hormone
  • Erythropoietin
  • Monoclonal Antibodies
  • Insulin
  • Interferon
  • Granulocyte-Colony Stimulating Factor

By Application:

  • Blood Disorders
  • Oncology Diseases
  • Chronic and Autoimmune Diseases
  • Growth Hormone Deficiencies

By Regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2015, 2016

Base year - 2017

Forecast period - 2018 to 2025

Target Audience of the Global G-CSF Biosimilars Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

TABLE OF CONTENTS

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
    • 1.3.1. G-CSF Biosimilars Market, by Type, 2015-2025 (USD Billion)
    • 1.3.2. G-CSF Biosimilars Market, by Application, 2015-2025 (USD Billion)
    • 1.3.3. G-CSF Biosimilars Market, by Region, 2015-2025 (USD Billion)
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. G-CSF Biosimilars Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. G-CSF Biosimilars Market Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. G-CSF Biosimilars Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Value Chain Analysis
    • 4.3.1. Supplier
    • 4.3.2. Manufacturers/Service Provider
    • 4.3.3. Distributors
    • 4.3.4. End-Users
  • 4.4. Key Buying Criteria
  • 4.5. Regulatory Framework
  • 4.6. Cost Structure Analysis
    • 4.6.1. Raw Material Cost Analysis
    • 4.6.2. Manufacturing Cost Analysis
    • 4.6.3. Labor Cost Analysis
  • 4.7. Investment Vs Adoption Scenario
  • 4.8. Analyst Recommendation & Conclusion

Chapter 5. G-CSF Biosimilars Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Key Market Players
  • 5.4. G-CSF Biosimilars Market, Sub Segment Analysis
    • 5.4.1. Human Growth Hormone
      • 5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.2. Erythropoietin
      • 5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.3. Monoclonal Antibodies
      • 5.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.4. Insulin
      • 5.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.5. Interferon
      • 5.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.6. Granulocyte-Colony Stimulating Factor
      • 5.4.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. G-CSF Biosimilars Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Key Market Players
  • 6.4. G-CSF Biosimilars Market, Sub Segment Analysis
    • 6.4.1. Blood Disorders
      • 6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.4.2. Oncology Diseases
      • 6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.4.3. Chronic and Autoimmune Diseases
      • 6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.4.4. Growth Hormone Deficiencies
      • 6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7. G-CSF Biosimilars Market, by Regional Analysis

  • 7.1. G-CSF Biosimilars Market, Regional Market Snapshot (2015-2025)
  • 7.2. North America G-CSF Biosimilars Market Snapshot
    • 7.2.1. U.S.
      • 7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.2.2. Canada
      • 7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.3. Europe G-CSF Biosimilars Market Snapshot
    • 7.3.1. U.K.
      • 7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.2. Germany
      • 7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.3. France
      • 7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.4. Rest of Europe
      • 7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.4. Asia G-CSF Biosimilars Market Snapshot
    • 7.4.1. China
      • 7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.2. India
      • 7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.3. Japan
      • 7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.4. Rest of Asia Pacific
      • 7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.5. Latin America G-CSF Biosimilars Market Snapshot
    • 7.5.1. Brazil
      • 7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.5.2. Mexico
      • 7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.6. Rest of The World
    • 7.6.1. South America
      • 7.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.6.2. Middle East and Africa
      • 7.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8. Competitive Intelligence

  • 8.1. Company Market Share (Subject to Data Availability)
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Pfizer
      • 8.3.1.1. Overview
      • 8.3.1.2. Financial (Subject to Data Availability)
      • 8.3.1.3. Product Summary
      • 8.3.1.4. Recent Developments
    • 8.3.2. Novartis
    • 8.3.3. Roche
    • 8.3.4. Merck & Co.
    • 8.3.5. Sanofi
    • 8.3.6. Johnson & Johnson
    • 8.3.7. Gilead Science
    • 8.3.8. GlaxoSmithKline
    • 8.3.9. AbbVie
    • 8.3.10. Amgen
    • 8.3.11. AstraZeneca
    • 8.3.12. Bayer

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
    • 9.1.6. Research Assumption
Back to Top